Two companies at Harvard Innovation Labs put together their efforts into a sharing biomedical data on a decentralized blockchain based platform. On top, a permission access platform is designed to provide secured access of the electronic health records. The key persons from these companies: Dr Chaudhary co-founder of Inkrypt and Kamran Khan CEO of Translo provide a few core concepts on the reasons their companies open up to play important roles in the electronic data records in the health industry.
The underlying system is set to provide hosting services on a private, secure and censorship-resistant cloud being accessible to everyone. While it ensures protection and data resilience through the distribution of encrypted data copies it also permits open access for the industry staff by cloacking the entire communication system in a layer of anonymity.
This platform has the capacity to host decentralized applications, an example being a publishing platform – currently named nLIGHTn -designed for content creation and citizen journalists. Such application is peer-to-peer interaction, secure and censorship-resistant which in the blockchain context means that once a transaction is completed, it cannot be altered and it cannot be stopped until it fulfill the completion.
The other company, Translo, prepares the medical data-sharing platform privacy encrypted designed to accelerate discoveries in the health industry. This technology creates a system which converts the health electronic records presenting a wide variety of formats into an interoperable standard industry format based on HL7, Health Level 7.
This novel system allows access to data in anonymous format in order to create faster patient recruitment which currently proves complicated due to specific health industry criterion. Also, the user interface of this technology in its new format has the ability to save costs significantly for drug development platforms as it enables coupling with Real World Evidence (RWE).
Most valuable propositions of this cutting edge health industry platform consist of:
- Interoperability of health care data
- Real World Evidence used in clinical trials
- Compliance with the Health Industry standards through distributed and secure hosting
- Complete autonomy and patients’ ownership
- Open data exchange in the global marketplace
The new system provides easier use, transparency and better patient care since data is translated to a standardized HL7 format. It also improves the time needed to find the suitable candidates for clinical trials by cutting it substantially to about 20% of what it presently takes.
While in the new environment the electronic health record systems interoperate, in the same time they provide complete histories of patients, a premier in the industry. The biopharmaceutical systems will also be able to run own analytics and data searching without third parties interventions. The blockchain underlying layer and distributed storage offer user security and privacy which surpasses HIPAA compliance, Health Insurance Portability and Accountability Act, a US law. Given all these, malicious parties would most likely fail to track, compromise or censor its data.